EP1316309A1 — Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy
Assigned to Orphan Medical Inc · Expires 2003-06-04 · 23y expired
What this patent protects
Disclosed are formulations of gamma-hydroxybutyrate in an acqueous medium that are resistant to microbial growth . Also disclosed are formulations of gamma-hydroxybutyrate that are also resistant to the conversion into GBL. Disclosed are methods to treat sleep disorders, includin…
USPTO Abstract
Disclosed are formulations of gamma-hydroxybutyrate in an acqueous medium that are resistant to microbial growth . Also disclosed are formulations of gamma-hydroxybutyrate that are also resistant to the conversion into GBL. Disclosed are methods to treat sleep disorders, including narcolepsy, with thesc stable formulations of GHB. The present invention also provides methods to treat alcohol and opiate withdrawal;, reduced levels of growth hormone, increased intracranial pressure, and physical pain in a patient.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.